KozaY. What is the clinical benefit of neutrophil–lymphocyte ratio in cardiovascular patients?J Cardiovasc Thorac Res. 2014;6(2):131–132.
2.
AzabBZaherMWeiserbsKF. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010;106(4):470–476.
3.
AvanzasPQuilesJLópez de SáE. Neutrophil count and infarct size in patients with acute myocardial infarction. Int J Cardiol. 2004;97(1):155–156.
4.
LiJFlammerAJRerianiMK. High leukocyte count is associated with peripheral vascular dysfunction in individuals with low cardiovascular risk. Circ J. 2013;77(3):780–785.
5.
SbranaFCocciFPapaA. Routine laboratory tests to risk-stratify patients with chronic coronary artery disease. J Cardiol. 2013;61(2):132–137.
6.
VaduganathanMAmbrosyAPGreeneSJ. Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail. 2012;5(6):750–758.
7.
HorneBDAndersonJLJohnJM. Which white blood cell subtypes predict increased cardiovascular risk?J Am Coll Cardiol. 2005;45(10):1638–1643.
8.
PanWZhaoDZhangC. Application of neutrophil/lymphocyte ratio in predicting coronary blood flow and mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention [published online January 2, 2015]. J Cardiol. 2015. doi:10.1016/j.jjcc.2014.10.014.
9.
SahinDYElbasanZGürM. Neutrophil to lymphocyte ratio is associated with the severity of coronary artery disease in patients with ST-segment elevation myocardial infarction. Angiology. 2013;64(6):423–429.
10.
KayaMGAkpekMLamYY. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study. Int J Cardiol. 2013;168(2):1154–1159.
11.
SenNAfsarBOzcanF. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Atherosclerosis. 2013;228(1):203–210.
12.
CiçekGAçıkgozSKBozbayM. Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [published online May 16, 2014]. Angiology. 2014. doi: 10.1177/0003319714535970.
13.
SmitJJOttervangerJPSlingerlandRJ. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction. Am J Cardiol. 2008;101(4):446–451.
14.
ParkJJJangHJOhIY. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;111(5):636–642.
15.
ChiaSNagurneyJTBrownDF. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol. 2009;103(3):333–337.
16.
SulaimanKAl-ZakwaniIPandurangaP. Relationship between white blood cell count and in-hospital outcomes in acute coronary syndrome patients from the Middle East. Angiology. 2012;63(1):24–29.
17.
AyçaBAkınFCelikO. Neutrophil to lymphocyte ratio is related to stent thrombosis and high mortality in patients with acute myocardial infarction [published online July 14, 2014]. Angiology. 2014. doi: 10.1177/0003319714542997.
18.
TamhaneUUAnejaSMontgomeryDRogersEKEagleKAGurmHS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102(6):653–657.
19.
KatsikiNAthyrosVGKaragiannisAMikhailidisDP. Contrast-induced nephropathy: an “all or none” phenomenon? [published online September 15, 2014]. Angiology. 2014. doi: 10.1177/0003319714550309.
20.
DemirkolSBaltaSKucukUKaramanMKucukHOKurtO. Neutrophil-to-lymphocyte ratio may predict contrast-induced nephropathy. Angiology. 2014;65(1):57–58.
21.
NunezJNunezEBodíV. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008;101(6):747–752.
22.
HeJLiJWangYHaoPHuaQ. Neutrophil-to-lymphocyte ratio (NLR) predicts mortality and adverse-outcomes after ST-segment elevation myocardial infarction in Chinese people. Int J Clin Exp Pathol. 2014;7(7):4045–4056.
23.
SabatineMSMorrowDACannonCP. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol. 2002;40(10):1761–1768.
24.
BaltaSCelikTMikhailidisDP. The relation between atherosclerosis and the neutrophil–lymphocyte ratio [published online February 9, 2015]. Clin Appl Thromb Hemost. 2015.
